Abstract
The type I interferon response protects cells against invading viral pathogens. The cellular factors that mediate this defence are the products of interferon-stimulated genes (ISGs). Although hundreds of ISGs have been identified since their discovery more than 25 years ago1,2,3, only a few have been characterized with respect to antiviral activity. For most ISG products, little is known about their antiviral potential, their target specificity and their mechanisms of action. Using an overexpression screening approach, here we show that different viruses are targeted by unique sets of ISGs. We find that each viral species is susceptible to multiple antiviral genes, which together encompass a range of inhibitory activities. To conduct the screen, more than 380 human ISGs were tested for their ability to inhibit the replication of several important human and animal viruses, including hepatitis C virus, yellow fever virus, West Nile virus, chikungunya virus, Venezuelan equine encephalitis virus and human immunodeficiency virus type-1. Broadly acting effectors included IRF1, C6orf150 (also known as MB21D1), HPSE, RIG-I (also known as DDX58), MDA5 (also known as IFIH1) and IFITM3, whereas more targeted antiviral specificity was observed with DDX60, IFI44L, IFI6, IFITM2, MAP3K14, MOV10, NAMPT (also known as PBEF1), OASL, RTP4, TREX1 and UNC84B (also known as SUN2). Combined expression of pairs of ISGs showed additive antiviral effects similar to those of moderate type I interferon doses. Mechanistic studies uncovered a common theme of translational inhibition for numerous effectors. Several ISGs, including ADAR, FAM46C, LY6E and MCOLN2, enhanced the replication of certain viruses, highlighting another layer of complexity in the highly pleiotropic type I interferon system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
de Veer, M. J. et al. Functional classification of interferon-stimulated genes identified using microarrays. J. Leukoc. Biol. 69, 912–920 (2001)
Knight, E., Jr & Korant, B. D. Fibroblast interferon induces synthesis of four proteins in human fibroblast cells. Proc. Natl Acad. Sci. USA 76, 1824–1827 (1979)
Larner, A. C. et al. Transcriptional induction of two genes in human cells by β interferon. Proc. Natl Acad. Sci. USA 81, 6733–6737 (1984)
Dupuis, S. et al. Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency. Nature Genet. 33, 388–391 (2003)
Keskinen, P. et al. Impaired antiviral response in human hepatoma cells. Virology 263, 364–375 (1999)
Brass, A. L. et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell 139, 1243–1254 (2009)
Brodsky, L. I. et al. A novel unsupervised method to identify genes important in the anti-viral response: application to interferon/ribavirin in hepatitis C patients. PLoS ONE 2, e584 (2007)
He, X. S. et al. Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race. Hepatology 44, 352–359 (2006)
Hilkens, C. M., Schlaak, J. F. & Kerr, I. M. Differential responses to IFN-α subtypes in human T cells and dendritic cells. J. Immunol. 171, 5255–5263 (2003)
Hultcrantz, M. et al. Interferons induce an antiviral state in human pancreatic islet cells. Virology 367, 92–101 (2007)
Indraccolo, S. et al. Identification of genes selectively regulated by IFNs in endothelial cells. J. Immunol. 178, 1122–1135 (2007)
Lanford, R. E. et al. Genomic response to interferon-α in chimpanzees: implications of rapid downregulation for hepatitis C kinetics. Hepatology 43, 961–972 (2006)
Leaman, D. W. et al. Novel growth and death related interferon-stimulated genes (ISGs) in melanoma: greater potency of IFN-β compared with IFN-α2. J. Interferon Cytokine Res. 23, 745–756 (2003)
Rani, M. R. et al. Novel interferon-β-induced gene expression in peripheral blood cells. J. Leukoc. Biol. 82, 1353–1360 (2007)
Sarasin-Filipowicz, M. et al. Interferon signaling and treatment outcome in chronic hepatitis C. Proc. Natl Acad. Sci. USA 105, 7034–7039 (2008)
Roy, S. et al. Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product. Science 247, 1216–1219 (1990)
Neil, S. & Bieniasz, P. Human immunodeficiency virus, restriction factors, and interferon. J. Interferon Cytokine Res. 29, 569–580 (2009)
Furtak, V. et al. Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity. PLoS ONE 5, e9081 (2010)
Blight, K. J., McKeating, J. A. & Rice, C. M. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 76, 13001–13014 (2002)
Liu, H. C., Niikura, M., Fulton, J. E. & Cheng, H. H. Identification of chicken lymphocyte antigen 6 complex, locus E (LY6E, alias SCA2) as a putative Marek’s disease resistance gene via a virus–host protein interaction screen. Cytogenet. Genome Res. 102, 304–308 (2003)
Spindler, K. R. et al. The major locus for mouse adenovirus susceptibility maps to genes of the hematopoietic cell surface-expressed LY6 family. J. Immunol. 184, 3055–3062 (2010)
Doria, M., Neri, F., Gallo, A., Farace, M. G. & Michienzi, A. Editing of HIV-1 RNA by the double-stranded RNA deaminase ADAR1 stimulates viral infection. Nucleic Acids Res. 37, 5848–5858 (2009)
Toth, A. M., Li, Z., Cattaneo, R. & Samuel, C. E. RNA-specific adenosine deaminase ADAR1 suppresses measles virus-induced apoptosis and activation of protein kinase PKR. J. Biol. Chem. 284, 29350–29356 (2009)
Frontini, M., Vijayakumar, M., Garvin, A. & Clarke, N. A. ChIP-chip approach reveals a novel role for transcription factor IRF1 in the DNA damage response. Nucleic Acids Res. 37, 1073–1085 (2009)
Zhou, A., Paranjape, J. M., Der, S. D., Williams, B. R. & Silverman, R. H. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways. Virology 258, 435–440 (1999)
Kuchta, K., Knizewski, L., Wyrwicz, L. S., Rychlewski, L. & Ginalski, K. Comprehensive classification of nucleotidyltransferase fold proteins: identification of novel families and their representatives in human. Nucleic Acids Res. 37, 7701–7714 (2009)
Isaacs, A. & Lindenmann, J. Virus interference. I. The interferon. Proc. R. Soc. Lond. B 147, 258–267 (1957)
Wilkins, C. & Gale, M., Jr Recognition of viruses by cytoplasmic sensors. Curr. Opin. Immunol. 22, 41–47 (2010)
Takaoka, A. & Yanai, H. Interferon signalling network in innate defence. Cell. Microbiol. 8, 907–922 (2006)
Bowie, A. G. & Unterholzner, L. Viral evasion and subversion of pattern-recognition receptor signalling. Nature Rev. Immunol. 8, 911–922 (2008)
Jones, C. T. et al. Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nature Biotechnol. 28, 167–171 (2010)
McGee, C. E. et al. Infection, dissemination, and transmission of a West Nile virus green fluorescent protein infectious clone by Culex pipiens quinquefasciatus mosquitoes. Vector Borne Zoonotic Dis. 10, 267–274 (2009)
Tsetsarkin, K. et al. Infectious clones of chikungunya virus (La Reunion isolate) for vector competence studies. Vector Borne Zoonotic Dis. 6, 325–337 (2006)
Suthar, M. S., Shabman, R., Madric, K., Lambeth, C. & Heise, M. T. Identification of adult mouse neurovirulence determinants of the Sindbis virus strain AR86. J. Virol. 79, 4219–4228 (2005)
Bick, M. J. et al. Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J. Virol. 77, 11555–11562 (2003)
Lindenbach, B. D. et al. Complete replication of hepatitis C virus in cell culture. Science 309, 623–626 (2005)
Lindenbach, B. D. & Rice, C. M. trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. J. Virol. 71, 9608–9617 (1997)
Petrakova, O. et al. Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in mammalian cells. J. Virol. 79, 7597–7608 (2005)
Zhang, Y. J. et al. Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type 1 attachment and infection. J. Virol. 76, 6332–6343 (2002)
Evans, M. J. et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446, 801–805 (2007)
Zennou, V. et al. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101, 173–185 (2000)
Jones, C. T., Murray, C. L., Eastman, D. K., Tassello, J. & Rice, C. M. Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus. J. Virol. 81, 8374–8383 (2007)
Acknowledgements
We thank the following investigators for contributing viral molecular clones: C. Stoyanov (YFV), S. Higgs (CHIKV), I. Frolov (WNV and VEEV), M. MacDonald and J. Law (SINV(ts6) and SINV-Fluc), M. Heise (SINV and SINV-GFP). We thank E. Jouanguy and J.-L. Casanova for STAT1−/− fibroblasts. We acknowledge the support of C. Zhao, X. Wang and W. Zhang at The Rockefeller University Genomics Resource Center. For technical advice, we thank S. Mazel and C. Bare at The Rockefeller University Flow Cytometry Resource Center, supported by the Empire State Stem Cell Fund through the New York State Department of Health (NYSDOH) contract no. C023046; the opinions expressed here are solely those of the authors and do not necessarily reflect those of the Empire State Stem Cell Fund, the NYSDOH or the State of New York. We thank M. Holz, E. Castillo and A. Webson for laboratory support; C. Murray for critical reading and editing of the manuscript; and A. Ploss, M. Scull, M. T. Catanese and S. You for discussions. This work was supported in part by National Institutes of Health grants AI057158 (Northeast Biodefense Center-Lipkin) to C.M.R. and AI064003 to P.B. Additional funding was provided by the Greenberg Medical Research Institute, the Starr Foundation and the Ronald A. Shellow, M.D. Memorial Fund (C.M.R.). J.W.S. and C.T.J. were supported by National Research Service Awards DK082155 and DK081193, respectively, from the National Institute of Diabetes and Digestive and Kidney Diseases.
Author information
Authors and Affiliations
Contributions
J.W.S. and C.M.R. designed the project. J.W.S., S.J.W., M.P., M.Y.M. and C.T.J. performed the experimental work. J.W.S., S.J.W., P.B. and C.M.R. analysed the results and wrote the manuscript. S.J.W., C.T.J. and P.B. contributed reagents and technical expertise.
Corresponding author
Ethics declarations
Competing interests
C.M.R. has equity in Apath, which holds commercial licences for the Huh-7.5 cell line and the HCVcc cell culture system. These licences are managed under The Rockefeller University policy.
Supplementary information
Supplementary Information
The file contains Supplementary Figures 1-13 with legends and Supplementary Tables 1-11. (PDF 3362 kb)
Rights and permissions
About this article
Cite this article
Schoggins, J., Wilson, S., Panis, M. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481–485 (2011). https://doi.org/10.1038/nature09907
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature09907
This article is cited by
-
Post-exposure intranasal IFNα suppresses replication and neuroinvasion of Venezuelan Equine Encephalitis virus within olfactory sensory neurons
Journal of Neuroinflammation (2024)
-
Pro-inflammatory feedback loops define immune responses to pathogenic Lentivirus infection
Genome Medicine (2024)
-
FEAR antiviral response pathway is independent of interferons and countered by poxvirus proteins
Nature Microbiology (2024)
-
UBR5 promotes antiviral immunity by disengaging the transcriptional brake on RIG-I like receptors
Nature Communications (2024)
-
Disulfiram ameliorates STING/MITA-dependent inflammation and autoimmunity by targeting RNF115
Cellular & Molecular Immunology (2024)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.